RENEW · Hormone and cellular care
Sermorelin
Understand your hormone signaling.
Explore a peptide that acts upstream of growth hormone release. A clinical evaluation can help put hormone-related concerns in context.
Prescription required. Provider evaluation determines eligibility.
Sermorelin is a synthetic fragment of growth-hormone-releasing hormone. It is different from taking growth hormone itself.
It acts through the pituitary signaling pathway associated with growth hormone release. A change in signaling does not guarantee changes in sleep, body composition or energy.
Administration depends on the exact formulation and prescription. Follow the prescriber and dispensing pharmacy’s instructions.
Your provider may review endocrine history, symptoms, medications, laboratory findings and whether another explanation or treatment is more appropriate.
Upstream signaling.
Individual decisions.
Sermorelin is a synthetic fragment of growth-hormone-releasing hormone. It is different from taking growth hormone itself.
-
Upstream signaling
Sermorelin is related to growth-hormone-releasing hormone.
-
Clinical context
Symptoms and laboratory information need interpretation together.
-
Individual decisions
A peptide may not be the appropriate next step.
Care starts with
understanding you.
A treatment decision should take your health history, current medications and goals into account. Your evaluation is the place to discuss questions, potential risks and whether another approach may be more appropriate.
-
Your health in context
Share your medical history, current medications and treatment goals.
-
A considered decision
Discuss the evidence, potential risks and available alternatives.
-
Clear next steps
If treatment is prescribed, follow the instructions for your exact medication and ask how follow-up will work.
Explore your options
with context.
Different treatments have different uses, risks and levels of evidence. Explore this care category, then discuss the options that may fit your clinical needs.
Explore hormone and cellular care-
Tesamorelin
Approved use concerns HIV-associated lipodystrophy.
Tesamorelin is a growth-hormone-releasing factor analog. Approved Egrifta products are indicated for excess abdominal fat in adults with HIV-associated lipodystrophy.
Learn more -
CJC/Ipamorelin
The precise CJC identity must be specified.
CJC-related peptides and ipamorelin are different substances. The CJC form, including whether it contains a drug affinity complex, must be identified.
Learn more -
Glutathione
Glutathione is present in human cells.
Glutathione is a molecule involved in cellular redox balance. Its natural presence does not mean that taking additional glutathione will produce a particular benefit.
Learn more
A plan begins with
an evaluation.
Completing an assessment does not guarantee a prescription.
-
Share your history
Provide information about your health, medications and goals.
-
Review the options
A licensed provider evaluates whether treatment is clinically appropriate. Further information, testing or another type of care may be needed.
-
Understand your prescription
If prescribed, review the medication, administration directions, risks and follow-up plan before starting.
-
Revisit the plan
Discuss your response and any concerns with your prescriber. Do not change a dose or combine treatments on your own.
Know the important
information.
Every medication has potential risks. Review the complete safety information for the exact product and tell your provider about your medical conditions, allergies, pregnancy or pregnancy plans, and all medicines and supplements you take.
Compounded medications are not FDA-approved. FDA does not evaluate these preparations for safety, effectiveness or quality before marketing.
Human safety data may be incomplete. Ingredient identity, purity, formulation and administration route matter; an ingredient’s research history does not establish the safety of a blend.
Seek emergency care for trouble breathing or swelling of the face, lips or throat. Contact a clinician promptly for severe or concerning symptoms. Do not rely on routine online messaging for an emergency.
Frequently asked questions
No. Sermorelin acts on signaling involved in growth hormone release.
No. Modern compounded adult wellness use should not be presented as FDA-approved anti-aging care.
Those results are not guaranteed. Discuss the evidence and alternatives for your particular concern.
A licensed provider considers your health history, current medications, clinical needs and the evidence for the specific treatment. Further testing or a different type of care may be recommended.
No. A prescription is provided only when the evaluating provider determines that treatment is medically appropriate and available.
Follow your prescriber and pharmacy's instructions for the exact product. Ask before changing a dose, switching formulations or combining treatments.
Your next step starts with your
health.
Share your history and goals so a licensed provider can evaluate which care options may be appropriate for you.
Prescription required. Treatment is not appropriate for everyone. Assessment does not guarantee a prescription.